RTI Biologics, Inc. (RTIX) Tops Q3 EPS by 1c
Tweet
Share
E-mailGet Alerts RTIX Hot Sheet
Price: $3.14 --0%
Financial Fact:
Marketing, general and administrative: 28.72M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Marketing, general and administrative: 28.72M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
RTI Biologics, Inc. (NASDAQ: RTIX) reported Q3 EPS of $0.05, $0.01 better than the analyst estimate of $0.04. Revenue for the quarter came in at $44.6 million versus the consensus estimate of $44.16 million.
For earnings history and earnings-related data on RTI Biologics, Inc. (RTIX) click here.
For earnings history and earnings-related data on RTI Biologics, Inc. (RTIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- L3Harris CEO steps down amid conduct review, shares drop
- BofA Securities Reiterates Buy Rating on Micron Technology (MU); Sees $230+ in EPS by FY30
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
